Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Quest Diagnostics (DGX) News Today

Quest Diagnostics logo
$241.48 -1.80 (-0.74%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$240.50 -0.99 (-0.41%)
As of 10/23/2026 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is Quest Diagnostics Down Today?

Quest Diagnostics Incorporated (NYSE: DGX) reported strong third-quarter results and raised its full-year outlook, but news of a cybersecurity breach involving patient data is weighing on investor sentiment. The breach may explain why the stock has been under pressure despite operational results that exceeded expectations.

  • Positive Sentiment: Third-quarter results beat estimates: Quest reported adjusted EPS of $3.00 versus the $2.87 consensus and revenue of $3.10 billion versus expectations of $3.05 billion. Revenue increased 10% year over year, while adjusted EPS rose 15.4%, reflecting stronger testing demand and margin improvement. Quest Diagnostics Reports Third Quarter 2026 Financial Results
  • Positive Sentiment: Full-year guidance was raised: Quest now expects 2026 revenue of $12.065 billion to $12.105 billion and adjusted EPS of $11.25 to $11.35, above consensus estimates of approximately $12.0 billion and $11.19, respectively. Organic requisition volume rose 14.4% in the quarter, and consumer-health revenue is expected to grow more than 30% for the year. Quest Diagnostics Earnings Takeaways
  • Positive Sentiment: Valuation and momentum remain supportive: Coverage characterized DGX as potentially undervalued following the guidance increase, while Zacks highlighted the company’s long-term momentum profile. Quest Diagnostics Could Be Undervalued
  • Neutral Sentiment: Deutsche Bank raised its price target to $245 from $232 but maintained a Hold rating, indicating improved expectations without a clear bullish endorsement. Deutsche Bank Adjusts Quest Diagnostics Price Target
  • Negative Sentiment: Patient-data breach creates a major overhang: Quest disclosed unauthorized access to its Quanum Lab Services Manager, a system used to order tests and access results. The company confirmed that personal and health information was compromised, potentially exposing it to regulatory scrutiny, litigation, remediation costs, and reputational damage. Quest Diagnostics Patient Data Breach
Posted 1+ days agoAI Generated. May Contain Errors.

Quest Diagnostics Latest News

Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings
Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening
Quest Diagnostics Earnings Call Signals Confident Growth
Quest Diagnostics (NYSE:DGX) Announces FY 2026 Earnings Guidance
Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript
What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call
Quest Diagnostics Boosts FY26 Outlook - Update
Quest Diagnostics Q3 2026: Volume surge powers a guidance raise
Quest’s (NYSE:DGX) Q3 2026 beats on revenue
Quest Diagnostics Q3 2026 Earnings Preview
Quest Diagnostics (DGX) Set to Announce Earnings on Thursday
Quest Diagnostics Inc's Dividend Analysis

Quest Diagnostics Media Mentions By Week

Quest Diagnostics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DGX
News Sentiment
▼
0.47

0.46
▲
Average
Healthcare
News Sentiment

Quest Diagnostics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DGX Articles
This Week
▼
38

6
▲
DGX Articles
Average Week

Quest Diagnostics Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
3
+200%
Page Views
4,723
+20%
Get Quest Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DGX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Quest Diagnostics dated 10/24/2026.
From Our Partners